NCT00857285 - Olmesartan Medoxomil Versus Losartan in Patients With Hypertension | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

September 30, 2003

Conditions

Essential Hypertension

Interventions

DRUG

olmesartan medoxomil

olmesartan medoxomil oral tablets, once daily for up to 12 weeks

DRUG

losartan potassium

losartan oral tablets, once daily for up to 12 weeks

Trial Locations (3)

Kaohsiung Medical University Hospital, Kaohsiung City

Chung Shun Medical University Hospital, Taichung

National Taiwan University Hospital, Taipei